BioPier Revenue and Competitors

Boston, MA USA

Location

N/A

Total Funding

Biotech

Industry

Estimated Revenue & Valuation

  • BioPier's estimated annual revenue is currently $3.4M per year.(i)
  • BioPier's estimated revenue per employee is $155,000

Employee Data

  • BioPier has 22 Employees.(i)
  • BioPier grew their employee count by -4% last year.

BioPier's People

NameTitleEmail/Phone
1
Lead Statistical Programmer/ConsultantReveal Email/Phone
2
Biostatistical AnalystReveal Email/Phone
3
Sr. Biostatistician, Study LeadReveal Email/Phone
4
PresidentReveal Email/Phone
5
Statistical AnalystReveal Email/Phone
6
Senior Biostatistical AnalystReveal Email/Phone
7
Senior Biostatistical Analyst, Lead eSubmission ProjectsReveal Email/Phone
8
Biostatistical AnalystReveal Email/Phone
9
Senior Biostatistical Analyst, Study LeadReveal Email/Phone
Competitor NameRevenueNumber of EmployeesEmployee GrowthTotal FundingValuation
#1
$12.7M82-45%$107.3MN/A
#2
$0.2M1-50%N/AN/A
#3
$6.2M4021%N/AN/A
#4
$42.2M2184%$165MN/A
#5
$14.6M94-37%$312.8MN/A
#6
$0.3M2-67%N/AN/A
#7
$235M366-5%$340.9MN/A
#8
$56M289-7%$7.6MN/A
#9
$4.7M6136%N/AN/A
#10
$2M138%N/AN/A
Add Company

What Is BioPier?

About BioPier We are a team of experienced biostatistical consultants. We specialize in biostatistical programming. Our team has an average of 10+ years of industry experience, and we operate 100% in the US (No off-shore operations) and we do not subcontract work. We serve high-profile pharmaceutical/biotechnology companies on their important clinical trials for global regulatory approvals. We have a great service history. We offer Clinical Workbenchâ„¢ product for clinical data review, patient profiling, and efficacy/safety reporting. We also provide E-submission (eCTD) services using our proprietary CRT Maker software.

keywords:N/A

N/A

Total Funding

22

Number of Employees

$3.4M

Revenue (est)

-4%

Employee Growth %

N/A

Valuation

N/A

Accelerator

Company NameRevenueNumber of EmployeesEmployee GrowthTotal Funding
#1
$1.5M22-19%N/A
#2
$4.7M22-19%N/A
#3
$3.1M22-4%N/A
#4
$2.2M2247%N/A
#5
$2.1M22100%N/A